Tori Whitacre Martonicz

IPs discuss APIC's white paper, which highlights IPs frustrations with outdated and unclear medical device IFUs and the challenges they face.

APIC and IPAC Canada introduce the EIPAC Decision-Making Framework to guide health care professionals through ethical dilemmas in infection prevention, promoting fair and transparent decision-making.

At HSPA 2024, Lila Price, CRCST, CER, CHL, and Dannie O. Smith, III, BSc, CSPDT, CRCST, CHL, CIS, CER, emphasized accurate instrument labeling and demonstrated a game to improve communication between the operating room and sterile processing departments.

Phase III trial of zoliflodacin shows it as effective as current treatments for uncomplicated gonorrhea, highlighting its potential in combating rising antibiotic resistance.

A new medical device uses microneedles and a suction cup to simplify blood sampling. It aids needle-phobic patients and benefits low-income regions with cost-effective diagnostics.

On May 16, 2024, Association for Professionals in Infection Control and Epidemiology (APIC) published its recommendations in a report on updating medical device instructions for use (IFUs).

Discover strategies to combat H5N1 influenza spillover in cattle, emphasizing collaborative efforts to ensure the safety of human, animal, and environmental well-being.

Lymphedema, a chronic condition often stemming from cancer treatments, leads to tissue swelling. Early detection through surveillance programs and proper skincare can prevent complications like infections.

A recent study’s results demonstrate that PuraCath Medical Inc.'s breakthrough UV-C device disinfects needleless connectors, potentially reducing CLABSI risks in hospital settings.

Health care has an unmet need for the treatment of herpesviruses, hepatitis B, and hepatitis D, which would enhance patient outcomes. What should be done, and what challenges do companies that are trying to develop treatments face?

Noah Wald-Dickler, MD, FACP, discusses the safety and efficacy of oral transition therapy, challenges in antimicrobial stewardship, and evidence-based alternatives presented at SHEA 2024.

Cheri Ackert-Burr, DNP, BAEd, RN, CNOR, CNS, AGTS, discusses optimizing drying strategies for medical devices, crucial in instrument processing, emphasizing efficiency gains and insights shared at the HSPA Annual Conference.

HSPA’s 2024-2025 president, Anthony Bondon, CRCST, CHL, BSM, AAS, SME, LSSYB, spoke with Infection Control Today to discuss his goals for his tenure and more.

Explore how Exeter Hospital revamped sustainability efforts, reducing waste, improving efficiency, and saving costs in the sterile processing department, as presented at HSPA 2024.

Discover how a playful, educational approach revolutionized continuous learning for a sterile processing department from a poster presented at the HSPA Conference 2024.

Check out the highlights so far from Infection Control Today at the Healthcare Sterile Processing Association held in Las Vegas, Nevada, from April 20 to April 23, 2024.

The CMCVAMC Sterile Processing Services Department presents their roadmap for success at HSPA 2024, focusing on workflow, instrumentation, tools, tracking, and SOPs.

CSSD at Siriraj Piyamaharajkarun Hospital presents a poster at HSPA 2024, outlining efforts to streamline loaner equipment management for surgical efficiency.

This presentation by Jill Holdsworth, MS, CIC, FAPIC, CRCST, NREMT, CHL, at HSPA 2024, focuses on understanding and implementing ANSI/AAMI ST79 Amendment 1 to improve environmental services in sterile processing.

Jill Holdsworth, MS, CIC, FAPIC, CRCST, NREMT, CHL, and Katie Belski, BSHCA, CRCST, CHL, CIS, spoke at the HSPA Annual Conference about being survey-ready. Listen to ICT's interview to learn more!

Lisa Pawlowski, DNP, MSN-Ed, RN, CRMST, presents a poster at the HSPA 2024 Conference highlighting an evidence-based bundle that reduces SSIs by improving post-use instrument care and storage practices.

Explore the fusion of process monitoring and situation awareness in sterile processing, fostering informed decision-making for safe patient care from a presentation at HSPA24.

Danielle Zerr, MD, MPH, explains her presentations at SHEA 2024 about strategies for environmental pathogen control, the significance of patient-centered care in health care settings, and respiratory viruses in pediatric settings.

Tisha Mitsunaga, DrPH, ScM, discusses innovative approaches fostering collaboration between public health and healthcare facilities to combat multidrug-resistant organism (MDRO) spread.

A study presented at the Society for Healthcare Epidemiology of America (SHEA) conference evaluated adherence to laxative administration guidelines before CDI testing in Veteran Affairs (VA) hospitals and explored associated demographic and contextual factors.

Discover strategies for advocating infection prevention programs to the C-suite, ensuring resources, leadership support, and impactful outcomes.

Ramon Zegpi Lagos, DVM, PhD, discusses H5N1 (avian flu), risks, transmission dynamics, preventive measures, and ongoing research at The Ohio State University.

Read on about how, as hospitals grapple with the costly burden of healthcare-associated infections (HAIs), artificial intelligence (AI) emerges as a game-changer in revolutionizing infection prevention strategies.

Merck's V116, a 21-valent pneumococcal vaccine, exhibits strong immunogenicity and coverage in diverse adult populations. Real-world data reveal its potential to combat pneumococcal diseases effectively.

Carole W. Kamangu, MPH, RN, CIC, shares her inspiring journey from the Democratic Republic of Congo to health care leadership in the US today. (This is the French translation of the interview with Carole W. Kamangu.)